CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vetoquinol Sa Company Snapshot
Vetoquinol Sa operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vetoquinol Sa with three other pharmaceutical manufacturers in Europe: FAES Farma SA of Spain (2017 sales of 274.58 million Euro [US$311.66 million] of which 84% was Speciality Pharmaceuticals), Biotest AG of Germany (378.10 million Euro [US$429.17 million] of which 83% was Therapy), and Dechra Pharmaceuticals PLC which is based in the United Kingdom (£359.28 million [US$455.93 million] of which 63% was European Pharmaceuticals).

Sales Analysis. During the year ended December of 2017, sales at Vetoquinol Sa were 352.17 million Euro (US$399.74 million). This is a very small increase of 0.5% versus 2016, when the company's sales were 350.35 million Euro. This was the fifth consecutive year of sales increases at Vetoquinol Sa (and since 2012, sales have increased a total of 18%). Sales of Asia Pacific (Rest of World) saw an increase that was more than double the company's growth rate: sales were up 10.3% in 2017, from 30.41 million Euro to 33.55 million Euro. Vetoquinol Sa also saw significant increases in sales in Americas (up 2.6% to 122.73 million Euro) . Not all segments of Vetoquinol Sa experienced an increase in sales in 2017: sales of Europe fell 2.2% to 195.90 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Vetoquinol Sa
  Stock Performance Chart for Vetoquinol Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (8/17/2018): 53.40
(Figures in Euro)
1 Week -2.6%   13 Weeks 2.3%  
4 Weeks 1.9%   52 Weeks 8.2%  
 
Vetoquinol Sa Key Data:
  Ticker: VETO Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 352,173,000
(Year Ending Jan 2018).
Employees: 2,120
  Currency: Euro Market Cap: 633,180,140
  Fiscal Yr Ends: December Shares Outstanding: 11,857,306
  Share Type: Action Ordinaires Closely Held Shares: 7,945,213
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.